State of Tennessee Department of Treasury Lowers Position in Progyny, Inc. (NASDAQ:PGNY)

State of Tennessee Department of Treasury trimmed its stake in shares of Progyny, Inc. (NASDAQ:PGNY - Free Report) by 54.7% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 37,388 shares of the company's stock after selling 45,198 shares during the quarter. State of Tennessee Department of Treasury's holdings in Progyny were worth $645,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the stock. Signaturefd LLC boosted its holdings in shares of Progyny by 1,355.0% in the 4th quarter. Signaturefd LLC now owns 1,455 shares of the company's stock valued at $25,000 after purchasing an additional 1,355 shares in the last quarter. GAMMA Investing LLC grew its holdings in shares of Progyny by 341.4% during the 4th quarter. GAMMA Investing LLC now owns 1,611 shares of the company's stock valued at $28,000 after purchasing an additional 1,246 shares during the last quarter. Nisa Investment Advisors LLC increased its position in Progyny by 108.4% during the 4th quarter. Nisa Investment Advisors LLC now owns 2,934 shares of the company's stock worth $51,000 after purchasing an additional 1,526 shares in the last quarter. Caitlin John LLC lifted its stake in Progyny by 2,974.8% in the 4th quarter. Caitlin John LLC now owns 3,290 shares of the company's stock valued at $57,000 after purchasing an additional 3,183 shares during the last quarter. Finally, Natixis bought a new stake in shares of Progyny during the fourth quarter worth $69,000. 94.93% of the stock is owned by institutional investors and hedge funds.

Progyny Stock Down 0.4 %

PGNY traded down $0.09 on Thursday, hitting $23.33. The company had a trading volume of 185,162 shares, compared to its average volume of 1,737,429. The business's fifty day simple moving average is $21.93 and its 200 day simple moving average is $19.43. Progyny, Inc. has a 12-month low of $13.39 and a 12-month high of $32.99. The company has a market cap of $2.00 billion, a PE ratio of 40.22, a PEG ratio of 2.39 and a beta of 1.37.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on PGNY. Bank of America boosted their price target on Progyny from $21.00 to $25.00 and gave the stock a "buy" rating in a report on Tuesday, February 11th. BTIG Research raised Progyny from a "neutral" rating to a "buy" rating and set a $28.00 price objective for the company in a report on Monday, March 31st. Canaccord Genuity Group increased their price objective on Progyny from $17.00 to $23.00 and gave the stock a "hold" rating in a report on Friday, February 28th. Finally, JPMorgan Chase & Co. boosted their price target on shares of Progyny from $17.00 to $23.00 and gave the company a "neutral" rating in a research report on Tuesday, January 28th. Eight investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $23.64.

About Progyny

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.